Search Results - "Egidi, M.F"

Refine Results
  1. 1

    Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review by Giannese, D., Ferro, F., Moriconi, D., Bonadio, A. G., Elefante, E., Egidi, M. F., Cupisti, A., Baldini, C.

    Published in CEN case reports (01-02-2021)
    “…Amyloid A nephropathy is a possible complication of chronic inflammatory disease. Proteinuria and kidney failure are the main features of the disease…”
    Get full text
    Journal Article
  2. 2

    Conversion to sirolimus in solid organ transplantation: a Single-Center experience by Egidi, M.F, Cowan, P.A, Naseer, A, Gaber, A.O

    Published in Transplantation proceedings (01-05-2003)
    “…Calcineurin inhibitors are associated with adverse events, including nephrotoxicity and diabetes that might reduce the benefits of long-term graft survival. We…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Polyomavirus in kidney and kidney--pancreas transplant recipients by Trofe, J., Gaber, L.W., Stratta, R.J., Shokouh-Amiri, M.H., Vera, S.R., Alloway, R.R., Lo, A., Gaber, A.O., Egidi, M.F.

    Published in Transplant infectious disease (01-03-2003)
    “…: Purpose. To report the incidence and clinical characteristics of polyomavirus (PV) nephritis in kidney (KTX) and kidney–pancreas transplant (KPTX)…”
    Get full text
    Journal Article
  4. 4

    Are Autoimmune Diseases or Glomerulonephritis Affecting the Development of Panel-Reactive Antibodies in Candidates for Renal Transplantation? by Showkat, A., Lo, A., Shokouh-Amiri, H., Nezakatgoo, N., Gaber, A.O., Mya, M., Egidi, M.F.

    Published in Transplantation proceedings (01-03-2005)
    “…Panel-reactive antibodies (PRA) are a major obstacle to kidney transplantation (KTx). It is not completely clear why only some patients develop PRA, whereas…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients by Lo, A, Egidi, M.F, Gaber, L.W, Gaber, A.O

    Published in Transplantation proceedings (01-05-2003)
    “…Sirolimus is the first of a group of mammalian target of rapamycin inhibitors to be introduced for clinical use in the United States. At the University of…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Evolving experience of hepatitis B virus prophylaxis in liver transplantation by Honaker, M.R., Shokouh-Amiri, M.H., Vera, S.R., Alloway, R.R., Grewal, H.P., Hardinger, K.L., Kizilisik, A.T., Bagous, T., Trofe, J., Stratta, R.J., Egidi, M.F., Gaber, A.O.

    Published in Transplant infectious disease (01-09-2002)
    “…: Passive immunoprophylaxis with hepatitis B immunoglobulin (HBIG) is important to prevent recurrence of hepatitis B virus (HBV) after orthotopic liver…”
    Get full text
    Journal Article
  7. 7

    Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis by Lo, A., Stratta, R.J., Egidi, M.F., Shokouh-Amiri, M.H., Grewal, H.P., Kisilisik, A.T., Trofe, J., Alloway, R.R., Gaber, L.W., Gaber, A.O.

    Published in Transplant infectious disease (01-03-2001)
    “…: Background: The impact of tacrolimus (TAC), mycophenolate mofetil (MMF) and steroid immunosuppression on cytomegalovirus (CMV) infection in combination with…”
    Get full text
    Journal Article
  8. 8

    Renal pathology and clinical presentations of polyomavirus nephropathy in simultaneous kidney pancreas transplant recipients compared with kidney transplant recipients by Gaber, L.W, Egidi, M.F, Lo, A, Gaber, A.O

    Published in Transplantation proceedings (01-05-2004)
    “…The purpose of this study was to describe and compare the renal histopathology and clinical course of simultaneous kidney-pancreas transplant (SKP) recipients…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation by Lo, A, Stratta, R J, Alloway, R R, Egidi, M F, Shokouh-Amiri, M H, Grewal, H P, Gaber, L W, Gaber, A O

    Published in Transplant international (01-12-2001)
    “…Since 1996, our standard immunosuppressive protocol for simultaneous kidney-pancreas transplantation (SKPT) has been tacrolimus (TAC), mycophenolate mofetil…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Human granulocytic ehrlichiosis in pancreas transplant recipients by Trofe, J., Reddy, K.S., Stratta, R.J., Flax, S.D., Somerville, K.T., Alloway, R.R., Egidi, M.F., Shokouh‐Amiri, M.H., Gaber, A.O.

    Published in Transplant infectious disease (01-03-2001)
    “…: Human ehrlichioses are tick‐borne infections caused by bacteria in the genus Ehrlichia of the family Rickettsiaceae. To date there have been three cases of…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20